Stocks · Healthcare · Medical - Care Facilities
Acadia Healthcare Company, Inc. ACHC
$28.06 +4.20% Close, Oct 2, 2026 · NASDAQ · Market cap $2.61B
High quality
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $-12.45, down 924.8% year over year.
- Earnings beat analyst estimates in each of the last 6 quarters (average surprise over the last four: +45.3%).
- The stock is in an uptrend: above its 200-day average for 153 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 38%
- EPS growth (TTM, YoY)Bottom 3%
- Revenue growth, 3-year CAGRBottom 45%
- Revenue growth accelerationBottom 34%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 21%
- Gross marginBottom 24%
- Operating marginTop 26%
- Accruals (lower is better)Top 10%
- Interest coverTop 36%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 17%
- Free-cash-flow yieldTop 38%
- EBITDA / enterprise valueBottom 34%
- Sales / enterprise valueTop 17%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 44%
- 6-month returnTop 42%
- 1-year return vs S&P 500Top 48%
- Distance from 52-week highTop 35%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 13%
- Consecutive EPS beatsTop 12%
- Share of analysts rating BuyBottom 37%
- Upside to consensus price targetBottom 29%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 43%
- Maximum drawdown, 3 yearsBottom 22%
- Beta vs S&P 500 (lower is better)Top 22%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 6.8% | 4.3% | ↓ |
| EPS growth (YoY) | -703.2% | -924.8% | ↓ |
| Gross margin | 81.2% | 35.6% | ↓ |
| Operating margin | 12.6% | 10.1% | ↓ |
| FCF margin | -9.6% | -0.6% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 4.3% | 6.8% | ↓ | Bottom 38% |
| EPS growth (TTM, YoY) | -924.8% | -703.2% | ↓ | Bottom 3% |
| Gross margin | 35.6% | 81.2% | ↓ | Bottom 24% |
| Operating margin | 10.1% | 12.6% | ↓ | Top 26% |
| Net margin | -33.4% | 4.3% | ↓ | — |
| Free-cash-flow margin | -0.6% | -9.6% | ↑ | — |
| Return on invested capital | 6.7% | — | Top 21% | |
| Revenue growth, 3-year CAGR | 8.3% | — | Bottom 45% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -24.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +10.7 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 2.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.15%
- Shareholder yield
- 0.15%
- Share count change, 1 year
- +1.0%
- Share count change, 3-year CAGR
- -0.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 28, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 6
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +45.3%
- Average 2-day reaction, last 8
- +4.2%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $34.78
- Target vs current price
- +23.9%
- Analysts with a rating
- 25
- Share rating Buy or Strong Buy
- 68%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 28, 2026 | +9.7% | +0.6% | -5.9% | -11.6% | — |
| Apr 29, 2026 | +32.1% | +2.5% | -8.4% | -12.7% | +25.1% |
| Feb 25, 2026 | +133.3% | +21.4% | +33.9% | +32.1% | +40.2% |
| Nov 5, 2025 | +5.9% | +0.1% | -11.7% | -28.9% | -36.1% |
| Aug 5, 2025 | +16.9% | +1.8% | -10.8% | +9.7% | +8.4% |
| May 12, 2025 | +14.3% | +8.4% | +9.7% | -7.8% | -24.5% |
| Feb 27, 2025 | -14.7% | -1.8% | -27.6% | -27.7% | -44.0% |
| Oct 30, 2024 | +1.1% | +0.9% | -17.6% | -20.5% | -15.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 28, 2026 | $0.38 | $0.35 | +9.7% | $865.8M |
| Apr 29, 2026 | $0.37 | $0.28 | +32.1% | $828.8M |
| Feb 25, 2026 | $0.07 | $0.03 | +133.3% | $821.5M |
| Nov 5, 2025 | $0.72 | $0.68 | +5.9% | $851.6M |
| Aug 5, 2025 | $0.83 | $0.71 | +16.9% | $869.2M |
| May 12, 2025 | $0.40 | $0.35 | +14.3% | $770.5M |
| Feb 27, 2025 | $0.64 | $0.75 | -14.7% | $774.2M |
| Oct 30, 2024 | $0.91 | $0.90 | +1.1% | $815.6M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 18.4× | — | — | — |
| EV / Sales | 1.49× | — | — | Top 17% |
| Free-cash-flow yield | -0.72% | — | — | Top 38% |
| Earnings yield | -44.39% | — | — | Bottom 17% |
P/E over the past five years
Range 12.7× – 28.9× since Dec 31, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +14.3%
- Earnings per share growth (TTM)
- -924.8%
- Change in P/E multiple
- +3.5%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 153
- 50-day average slope (20 days)
- -4.6%
- 200-day average slope (20 days)
- +5.6%
- Distance from 50-day average
- -3.8%
- Distance from 200-day average
- +16.1%
- RSI (14)
- 48.3
- Relative volume
- 1.02×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 59.4%
- Volatility vs own 5-year history
- 77th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.62
- Correlation with S&P 500
- 0.14
- Current drawdown from 1-year high
- -21.2%
- Maximum drawdown, 3 years
- -86.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 30, 2022 | Jan 16, 2026 | -86.9% | 784 days | Not yet recovered |
| Sep 2, 2021 | Feb 7, 2022 | -25.9% | 108 days | 41 days (Apr 6, 2022) |
| Apr 20, 2022 | Jun 14, 2022 | -16.1% | 38 days | 21 days (Jul 15, 2022) |
| Oct 15, 2020 | Oct 28, 2020 | -14.3% | 9 days | 2 days (Oct 30, 2020) |
| Jun 11, 2021 | Jul 19, 2021 | -14.0% | 25 days | 33 days (Sep 2, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $2.61B
- EPS, diluted (TTM)
- -$12.45
- Revenue (TTM)
- $3.37B
- 52-week range
- $11.43 – $35.83
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $2.31B | $2.61B | $2.93B | $3.15B | $3.31B |
| Gross profit | $2.22B | $2.51B | $682.6M | $712.0M | $583.4M |
| Operating income | $414.5M | $467.7M | $506.6M | $522.3M | $388.0M |
| Net income | $190.6M | $273.1M | -$21.7M | $255.6M | -$1.10B |
| EPS (diluted) | $2.10 | $2.98 | -$0.24 | $2.78 | -$12.16 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $815.6M | $774.2M | $770.5M | $869.2M | $851.6M | $821.5M | $828.8M | $865.8M |
| Net income | $68.1M | $32.6M | $8.4M | $30.1M | $36.2M | -$1.18B | $4.1M | $10.9M |
| EPS (diluted) | $0.74 | $0.35 | $0.09 | $0.33 | $0.40 | -$13.02 | $0.05 | $0.12 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $374.5M | $380.6M | $462.3M | $129.7M | $131.9M |
| Capital expenditure | -$244.8M | -$296.1M | -$424.1M | -$690.4M | -$571.8M |
| Free cash flow | $129.7M | $84.4M | $38.2M | -$560.7M | -$439.9M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$5.7M | $0 | -$52.5M | -$8.6M | -$50.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $171.3M
- Total assets
- $5.55B
- Total liabilities
- $3.35B
- Total debt
- $2.56B
- Net debt
- $2.39B
- Shareholders’ equity
- $1.98B
As of Jun 30, 2026 (filed Jul 28, 2026).
Short interest
- Shares sold short
- 21,509,968
- Days to cover
- 18.79
- Change vs previous report
- -4.8%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Nov 1, 2011
- 1-for-4